Newron Pharmaceuticals S.p.A.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
49.00 |
18.74 |
53.41 |
120.05 |
170.30 |
195.43 |
| Przychód Δ r/r |
0.00% |
-61.74% |
184.92% |
124.78% |
41.86% |
14.75% |
| Przychód (min) |
27.77 |
7.38 |
9.35 |
28.74 |
40.77 |
46.78 |
| Przychód (max) |
60.92 |
33.45 |
128.63 |
267.11 |
378.93 |
434.83 |
| EBITDA (średnia) |
-26.05 |
-13.10 |
-37.33 |
-83.92 |
-119.05 |
-136.61 |
| EBIT (średnia) |
-26.75 |
-13.12 |
-37.37 |
-84.01 |
-119.18 |
-136.76 |
| EBIT % |
-54.59% |
-69.98% |
-69.98% |
-69.98% |
-69.98% |
-69.98% |
| Zysk netto (średni) |
-25.86 |
-16.13 |
7.19 |
68.40 |
87.39 |
101.03 |
| Zysk netto % |
-52.79% |
-86.06% |
13.46% |
56.97% |
51.31% |
51.70% |
| EPS (średnia) |
1.61 |
-0.87 |
0.39 |
3.68 |
4.71 |
5.44 |
| Liczba analityków (Przychody) |
3 |
3 |
3 |
1 |
1 |
2 |
| Liczba analityków (EPS) |
3 |
3 |
3 |
1 |
1 |
1 |
| symbol |
NWRN.SW |
NWRN.SW |
NWRN.SW |
NWRN.SW |
NWRN.SW |
NWRN.SW |